source
- Experts urge FDA to require credentials for psychedelic therapy providersAt a recent public hearing, mental health experts called on the FDA to adopt safety measures as it pushes to speed up psychedelic therapy development. The experts specifically recommended that pro…
- Sionna Therapeutics to lay off 46% of staff after cystic fibrosis trial setbackSionna Therapeutics announced it will cut 46% of its workforce following an unexpected failure in its cystic fibrosis trial. The company, which employed about 59 people, said roughly 27 employees…